Stratifying management of rheumatic disease for pregnancy and breastfeeding

Ian Giles; Caroline Gordon; Chee-Seng Yee

doi:10.1038/s41584-019-0240-8

Stratifying management of rheumatic disease for pregnancy and breastfeeding

Ian Giles, Caroline Gordon, Chee-Seng Yee

Inflammation and Ageing

Research output: Contribution to journal › Review article › peer-review

12 Citations (Scopus)

395 Downloads (Pure)

Abstract

The management of inflammatory rheumatic diseases during pregnancy and breastfeeding has undergone considerable change in the past few years. Modern therapeutics, including biologic and targeted synthetic DMARDs, have enabled substantial improvements in the control of rheumatic diseases, resulting in more patients with severe disease considering pregnancy. Therefore, management of disease for these patients needs to be discussed with clinicians before, during and after pregnancy and patients need to know what complications they might experience before they become pregnant. This Review summarizes the effects pregnancy has on various rheumatic diseases and the effects these diseases have on pregnancy, as well as providing advice regarding the alteration and monitoring of therapy before, during and after pregnancy.

Original language	English
Pages (from-to)	391–402
Number of pages	12
Journal	Nature Reviews Rheumatology
Volume	15
Issue number	7
Early online date	11 Jun 2019
DOIs	https://doi.org/10.1038/s41584-019-0240-8
Publication status	Published - Jul 2019

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1038/s41584-019-0240-8Licence: None: All rights reserved

Giles_et_al_Stratifying_management_of_rheumatic_Nature_2019
Checked for eligibility: 30/05/2019 This is the accepted manuscript version of a published work that appeared in its final form in Nature Reviews Rheumatology. The final version of record can be found at: https://doi.org/10.1038/s41584-019-0240-8 This manuscript is subject to Nature's re-use terms: https://www.nature.com/authors/policies/license.html#terms
Accepted author manuscript, 307 KBLicence: Other (please specify with Rights Statement)

Cite this

@article{aba265b078244fc2b143b1629f0c4d8a,

title = "Stratifying management of rheumatic disease for pregnancy and breastfeeding",

abstract = "The management of inflammatory rheumatic diseases during pregnancy and breastfeeding has undergone considerable change in the past few years. Modern therapeutics, including biologic and targeted synthetic DMARDs, have enabled substantial improvements in the control of rheumatic diseases, resulting in more patients with severe disease considering pregnancy. Therefore, management of disease for these patients needs to be discussed with clinicians before, during and after pregnancy and patients need to know what complications they might experience before they become pregnant. This Review summarizes the effects pregnancy has on various rheumatic diseases and the effects these diseases have on pregnancy, as well as providing advice regarding the alteration and monitoring of therapy before, during and after pregnancy.",

author = "Ian Giles and Caroline Gordon and Chee-Seng Yee",

year = "2019",

month = jul,

doi = "10.1038/s41584-019-0240-8",

language = "English",

volume = "15",

pages = "391–402",

journal = "Nature Reviews Rheumatology",

issn = "1759-4790",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - Stratifying management of rheumatic disease for pregnancy and breastfeeding

AU - Giles, Ian

AU - Gordon, Caroline

AU - Yee, Chee-Seng

PY - 2019/7

Y1 - 2019/7

N2 - The management of inflammatory rheumatic diseases during pregnancy and breastfeeding has undergone considerable change in the past few years. Modern therapeutics, including biologic and targeted synthetic DMARDs, have enabled substantial improvements in the control of rheumatic diseases, resulting in more patients with severe disease considering pregnancy. Therefore, management of disease for these patients needs to be discussed with clinicians before, during and after pregnancy and patients need to know what complications they might experience before they become pregnant. This Review summarizes the effects pregnancy has on various rheumatic diseases and the effects these diseases have on pregnancy, as well as providing advice regarding the alteration and monitoring of therapy before, during and after pregnancy.

AB - The management of inflammatory rheumatic diseases during pregnancy and breastfeeding has undergone considerable change in the past few years. Modern therapeutics, including biologic and targeted synthetic DMARDs, have enabled substantial improvements in the control of rheumatic diseases, resulting in more patients with severe disease considering pregnancy. Therefore, management of disease for these patients needs to be discussed with clinicians before, during and after pregnancy and patients need to know what complications they might experience before they become pregnant. This Review summarizes the effects pregnancy has on various rheumatic diseases and the effects these diseases have on pregnancy, as well as providing advice regarding the alteration and monitoring of therapy before, during and after pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=85067388236&partnerID=8YFLogxK

U2 - 10.1038/s41584-019-0240-8

DO - 10.1038/s41584-019-0240-8

M3 - Review article

SN - 1759-4790

VL - 15

SP - 391

EP - 402

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

IS - 7

ER -

Stratifying management of rheumatic disease for pregnancy and breastfeeding

Abstract

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this